Stem Cell Center Articles & Analysis
6 news found
Center for Medicare and Medicaid Services (CMS). This new CMS code to be submitted by hospitals performing the CardiAMP cell therapy procedure is available April 1, 2022. ...
The CardiAMP Cell Therapy Heart Failure Trial is the first multicenter clinical trial of a stem cell therapy to prospectively screen for stem cell therapeutic potency in order to improve patient outcomes. CardiAMP Cell Therapy incorporates three proprietary elements not previously utilized in ...
Tiago Fleming Outeiro, PhD (University Medical Center Göttingen) will discuss protein misfolding in neurodegenerative diseases. ...
– Oct. 29, 2021 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced the publication of the peer-reviewed manuscript, “Co-grafts of Human Stem Cell-Derived Retina Organoids and Retinal Pigment Epithelium for Retinal Reconstruction in Immunodeficient ...
This is the first trial in the United States to study pluripotent stem cell-derived dopaminergic neurons in patients with Parkinson’s disease. ...
U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced Phil Posa has joined its executive management team as Senior Vice President of U.S. ...